- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03384134
Treating Pain in Children With Cancer: Pain Buddy
Mobile Technology to Improve Pain and Symptoms in Children With Cancer
Study Overview
Detailed Description
Approximately 12,000 children are diagnosed with cancer in the United States each year and the majority of these children will experience moderate to severe pain and disabling symptoms such as fatigue and nausea during the course of their illness. Survivors of childhood cancer are also at high-risk for long-term chronic pain. Unfortunately, the World Health Organization (WHO) indicates that current efforts to manage pain in pediatric oncology patients are seriously inadequate. Reasons for under treatment of pain and symptoms in children diagnosed with cancer are complex and are likely related to deficits in the process of assessment and management as well as lack of timely access to pharmacological and non-pharmacological interventions. Management of pain in this population is also compounded by the fact that increasing numbers of children currently receive chemotherapy on an outpatient basis due to advances in healthcare and changes in the medical-economical environment.
To date, interventions targeting pain and symptom management in the home setting of children suffering from cancer are seriously lacking. To address this significant gap, the candidate is proposing significant training in pediatric cancer pain and symptom management and an innovative two-phase research strategy. The first phase of research will focus on the development and formative evaluation of an innovative handheld electronic program (Pain Buddy) that provides remote monitoring of pain and symptoms and delivery of cognitive and behavioral skills training to children undergoing treatment for cancer. The second phase of this application involves evaluation of the efficacy of the program using a randomized controlled trial design. Pain Buddy will allow for collection of "real time" pain and symptom data that will be transmitted immediately and monitored remotely by the oncology treatment team. Remote symptom monitoring in real time will provide an opportunity for timely implementation of appropriate interventions, thereby introducing the potential to decrease pain and symptoms and improve quality of life. Pain Buddy will also deliver psychosocial skills training, teaching cognitive and behavioral strategies to manage pain and symptom-related distress. The skills training will target coping and self-efficacy in children without the need for face-to-face intervention which is not feasible in the majority of settings. Symptom monitoring and skills training will further increase patient engagement in their own health care, which is a main goal of the Institute of Medicine and many other organizations. The objectives outlined above will be accomplished by the following specific aims:
PHASE I: Development and Formative Evaluation Specific Aim 1: Through collaboration with the California Institute for Telecommunications and Information Technology (Calit2), develop and examine the usability of a cognitive and behavioral skills training intervention (Pain Buddy) delivered via electronic, handheld technology in conjunction with a validated pain and symptom assessment protocol (Jacob, E.) that will allow for monitoring of and response to pain and symptoms of pediatric oncology patients in real time.
Hypothesis 1. Children and their parents will demonstrate the ability to use Pain Buddy on the electronic device and will rate high levels of acceptability, usability and satisfaction on beta testing.
PHASE II: Randomized Controlled Trial of Pain Buddy Specific Aim 2: Using a randomized controlled trial design, we will examine the efficacy of Pain Buddy in managing pain and symptoms in children suffering from cancer.
Hypothesis 2. Children enrolled in the Pain Buddy group will report lower symptom-related distress as measured by the Memorial Symptom Assessment Scale (MSAS), compared to children in the monitoring group (primary outcome).
Hypothesis 3. Children in the Pain Buddy group will evidence lower pain severity and higher quality of life compared with children in the monitoring group (secondary outcomes).
Hypothesis 4. Children and nurses will demonstrate high rates of compliance (85% or greater) with Pain Buddy (secondary outcome).
The long-term goals of this research are to develop a usable, engaging electronic decision-support pain and symptom management intervention for children receiving outpatient chemotherapy using Smartphone technology and to examine the efficacy of the electronic decision-support intervention on children's pain and quality of life. These long-term goals will be accomplished through assessment of the data collected from patients, parents and physicians using the ambulatory monitoring protocol.
PHASE III: Multi-Site Randomized Controlled Trial of Pain Buddy
Primary Aim: Determine if Pain Buddy is more effective than attention control in reducing pain severity among children ages 8-18 years old undergoing outpatient cancer treatment.
Secondary Aims:
- Examine the impact of Pain Buddy on symptom-related distress, health-related quality of life, functional status, and satisfaction with treatment experience.
- Determine whether baseline characteristics of children (emotional functioning) and parents (stress, attitudes regarding analgesic use for children) moderate the effect of Pain Buddy on pain severity.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Haydee G Cortes, BA
- Phone Number: 714-456-2838
- Email: cortesh@uci.edu
Study Contact Backup
- Name: Lessley B Torres, BA
- Phone Number: 714-456-2835
- Email: lessleyt@hs.uci.edu
Study Locations
-
-
California
-
Orange, California, United States, 92868
- Recruiting
- University of California, Irvine
-
Contact:
- Haydee Cortes, BA
- Phone Number: 714-456-2837
- Email: cortesh@uci.edu
-
Contact:
- Michelle A Fortier, Ph.D.
- Phone Number: 714-456-2833
- Email: mfortier@uci.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between the ages of 8-18 years
- Currently undergoing outpatient treatment for cancer
- Patients who are able to speak, read, and write in English. Parents who are able to speak, read, and write in English or Spanish
- Have home internet access to use Pain Buddy (the internet will be used to securely send the pain information to the research team).
Exclusion Criteria:
- Cognitive impairment, such as a developmental delay or mental retardation that would prevent children from being able to use the Pain Buddy program.
- Children diagnosed with acute myelogenous leukemia (AML) or acute promyelocytic leukemia (APL) as the treatment protocols for these children are largely inpatient, precluding use of the intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pain Buddy
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily diaries using Pain Buddy and will also be taught cognitive and behavioral coping skills, like deep breathing, imagery, and relaxation, to deal with pain and symptoms.
The skills will be taught through the electronic tablet.
Pain and symptom information, collected daily by Pain Buddy, will be sent to a health care provider on the oncology treatment team, who will contact patients when certain thresholds are reached and will instruct the patients on best ways to control pain and symptoms.
|
Pain Buddy is a user interface (application) which contains a personalized avatar (Pain Buddy) to guide children and parents through daily diary entries using mobile devices.
The Pain Buddy application has been designed to be used with children age 8-18, receiving outpatient chemotherapy, as well as their parents.
Pain Buddy will capture real time pain data from patients and that will ultimately allow for remote monitoring of patient symptoms.
Remote symptom monitoring in real time will provide an opportunity for implementation of appropriate interventions, thereby introducing the potential to decrease pain and symptoms and improve quality of life in children with cancer.
The use of symptom monitoring and skills training will further increase patient engagement in healthcare.
|
No Intervention: Control
Children in this condition will continue with the care that has been prescribed for cancer- and chemotherapy-related pain and symptoms, which may include medications, medical visits, physical interventions, etc. Participants in this condition will complete daily pain diaries using Pain Buddy, but will not receive skills training or remote monitoring of data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in prevalence and intensity of pain episodes and other distressing physical and psychological symptoms.
Time Frame: Baseline and day 60
|
As part of the daily electronic Pain Buddy diary, children are administered the Memorial Symptoms Assessment Scale.
Children 8-9 receive an 8-item instrument and are asked to report frequency (i.e. a very short time, a medium amount, almost all the time) severity (i.e. a little, a medium amount, very), and how distressful (i.e.
not at all, a little, a medium amount, very) each symptom was.
Children 10-18 receive a 30-item instrument and are asked to report how often (i.e.
almost never, sometimes, a lot, almost always), how severe (i.e.
slight, moderate, severe, very severe), and how distressful (i.e.
not at all, a little bit, somewhat, quite a bit, very much) each symptom was.
|
Baseline and day 60
|
Changes in pain severity, location, and affective dimensions
Time Frame: Baseline and day 60
|
Child's pain is assessed using the 3 components of the Adolescent Pediatric Pain Tool. 1. Children use a body outline/map to identify areas they are experiencing pain.
2. Children report pain intensity from "not in pain" (score of 0) and "worst pain" (score of 100) using the 100-mm Visual Analog Scale for Pain.
3. Children are presented with a pain quality word descriptor list within 4 categories (Sensory, affective, evaluative, and temporal).
|
Baseline and day 60
|
Changes in children's quality of life since using Pain Buddy is assessed using the Pediatric Quality of Life Inventory (child self-report, ages 8-12, 13-18; parent report child ages 8-12, 13-18)
Time Frame: Baseline, day 60, and day 180
|
Children and parents are asked to report on the child's health related quality of life.
The measure incorporates a generic, cancer, and fatigue module and asks question on a 5-point likert scale from 0 ("Never") to 4 ("Almost Always") For questions like "I have trouble sleeping."
Higher scores on the scale suggest a better health related quality of life.
These responses are useful in understanding pain information collected in Pain Buddy.
|
Baseline, day 60, and day 180
|
Changes in Children's Anxiety and Depression assessed using the Revised Child Anxiety and Depression Scale (RCADS)
Time Frame: Baseline, day 60, and day 180
|
Parent and Child's self report on 47-item scale with subscales including separation anxiety, social phobia, generalized anxiety, panic disorder, obsessive compulsive disorder, and major depression.
Items are rated on a 4-point Likert scale from 0 ("never") to 3 ("always").
Higher scores suggest higher levels of anxiety and depression.
|
Baseline, day 60, and day 180
|
State-Trait Anxiety Inventory (STAI) (parent self-report)
Time Frame: Baseline
|
Only the Trait section of the questionnaire is administered to parents to assess their self reported anxiety.
Items rated on a 4-point Likert Scale from 1 ("Almost Never") to 4 ("Almost Always").
Higher scores suggest higher levels of anxiety.
|
Baseline
|
Changes in Perceived Stress (parent self-report)
Time Frame: Baseline, day 60, and day 180
|
Parents are administered the 14-item Perceived Stress Scale and asked to rate statements such as "In the past month, how often have you been upset because of something that happened unexpectedly?"
and "In the past month how often have you felt that things were going your way?" Subjects rate the items on a 5-point Likert-type scale with higher scores reflecting greater perceived stress.
|
Baseline, day 60, and day 180
|
Medication Attitude Questionnaire (MAQ) (parent self-report)
Time Frame: Baseline
|
Parents were asked to report their attitudes regarding use of pain medication for treating children's pain.
The factors assessed were Appropriate-Use (e.g., "Giving children pain medication for pain teaches proper use of drugs"), Side-Effects (e.g., "Side effects are something to worry about when giving children pain medication"), and Avoidance (e.g., "Pain medication works best if saved for when the pain is quite bad").
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michelle A Fortier, Ph.D., University of California, Irvine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 120111 UCI AA #2019-5027
- 1R01CA222012-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
Clinical Trials on Pain Buddy
-
Radboud University Medical CenterDutch Cancer SocietyRecruiting
-
The University of Texas at ArlingtonUniversity of South Florida; Center for Transportation, Equity, Decisions and...CompletedLack of Resources | Lack of MobilityUnited States
-
Birmingham Community Healthcare NHSBirmingham City UniversityCompleted
-
University Medical Center GroningenNot yet recruiting
-
Boston Medical CenterNational Cancer Institute (NCI); Northeastern UniversityCompletedPatient Satisfaction | Patient Compliance | Guideline AdherenceUnited States
-
Sally CHANActive, not recruiting
-
Wolfson Medical CenterUnknown
-
University GhentResearch Foundation FlandersCompletedPhysical Activity | Intellectual Disability | Health Promotion | AdolescentsBelgium
-
University of California, Los AngelesBodiMojo, Inc.CompletedIrritable Bowel Syndrome | Abdominal PainUnited States
-
Cairo UniversityRecruitingPulmonary Disease, Chronic ObstructiveEgypt